Aequim Alternative Investments’s Jazz Pharmaceuticals JAZZ Stock Holding History

Aequim Alternative Investments’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-16,700	Closed	-$2.2M	–	106
2025 Q3	$2.2M	Hold	16,700	–	–	0.05%	82
2025 Q2	$1.77M	Hold	16,700	–	–	0.06%	82
2025 Q1	$2.07M	Hold	16,700	–	–	0.08%	76
2024 Q4	$2.06M	Sell	16,700 -9,200	-36%	-$1.08M	0.07%	82
2024 Q3	$2.89M	Hold	25,900	–	–	0.1%	80
2024 Q2	$2.76M	Hold	25,900	–	–	0.1%	78
2024 Q1	$3.12M	Hold	25,900	–	–	0.12%	77
2023 Q4	$3.19M	Buy	25,900 +19,300	+292%	+$2.41M	0.13%	71
2023 Q3	$854K	Hold	6,600	–	–	0.03%	93
2023 Q2	$818K	Hold	6,600	–	–	0.03%	92
2023 Q1	$966K	Hold	6,600	–	–	0.03%	108
2022 Q4	$1.05M	Hold	6,600	–	–	0.03%	117
2022 Q3	$880K	Hold	6,600	–	–	0.03%	118
2022 Q2	$1.03M	Hold	6,600	–	–	0.03%	120
2022 Q1	$1.03M	Hold	6,600	–	–	0.03%	126
2021 Q4	$841K	Hold	6,600	–	–	0.03%	110
2021 Q3	$859K	Hold	6,600	–	–	0.03%	93
2021 Q2	$1.17M	Hold	6,600	–	–	0.05%	91
2021 Q1	$1.08M	Hold	6,600	–	–	0.07%	78
2020 Q4	$1.09M	Hold	6,600	–	–	0.08%	70
2020 Q3	$941K	Hold	6,600	–	–	0.13%	62
2020 Q2	$728K	Buy	+6,600	New	+$730K	0.11%	57

Other funds holding JAZZ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Aequim Alternative Investments's JAZZ Position: Q4 2025 in Review

Aequim Alternative Investments sold out of Jazz Pharmaceuticals (JAZZ) in Q4 2025, closing a stake of 16,700 shares — an estimated $2.2M sold.

Aequim Alternative Investments first reported a position in JAZZ in Q2 2020 and held it in 22 quarters. The position peaked at $3.19M in Q4 2023. 573 funds tracked by Wall St. Rank hold JAZZ as of Q4 2025.

Aequim Alternative Investments reported no remaining Jazz Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
Aequim Alternative Investments sold 16,700 Jazz Pharmaceuticals shares in Q4 2025, an estimated $2.2M.
Aequim Alternative Investments first reported a position in Jazz Pharmaceuticals in Q2 2020 and held it in 22 quarters.
Aequim Alternative Investments's Jazz Pharmaceuticals position peaked at $3.19M in Q4 2023.
573 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2025.

Based on Aequim Alternative Investments's 13F filing for Q4 2025, filed 17 Feb 2026.